Neoplasms Metastasis Recruiting Phase 1 / 2 Trials for Regorafenib (DB08896)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02406170Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric CarcinomaTreatment